Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation?

Jordi Heijman (First author)
, N Voigt
, S Ghezelbash
, I Schirmer
, D Dobrev

Research output: Contribution to journal › Review

21 Citations (Web of Science)

Original language	English
Journal	Journal of Cardiovascular Pharmacology
DOIs	https://doi.org/10.1097/FJC.0000000000000253
Publication status	Published - 2015

Branches of science

107 Other Natural Sciences
301 Medical-Theoretical Sciences, Pharmacy
304 Medical Biotechnology

DOI

10.1097/FJC.0000000000000253

Links

Cite this

@article{14103564a38042ed944341626bfdfe4e,

title = "Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation?",

author = "Jordi Heijman and N Voigt and S Ghezelbash and I Schirmer and D Dobrev",

year = "2015",

doi = "10.1097/FJC.0000000000000253",

language = "English",

journal = "Journal of Cardiovascular Pharmacology",

issn = "0160-2446",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation?

AU - Voigt, N

AU - Ghezelbash, S

AU - Schirmer, I

AU - Dobrev, D

A2 - Heijman, Jordi

PY - 2015

Y1 - 2015

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000366713400001

UR - https://pubmed.ncbi.nlm.nih.gov/25830486

U2 - 10.1097/FJC.0000000000000253

DO - 10.1097/FJC.0000000000000253

M3 - Review

C2 - 25830486

SN - 0160-2446

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

ER -